STATE STREET CORP - GEMINI THERAPEUTICS INC ownership

GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 2 filers reported holding GEMINI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of GEMINI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$167,000
-2.9%
101,8990.0%0.00%
Q2 2022$172,000
-69.7%
101,899
-75.1%
0.00%
Q1 2022$568,000
-52.7%
408,704
-0.9%
0.00%
Q4 2021$1,200,000
-28.5%
412,215
-0.7%
0.00%
Q3 2021$1,678,000
-15.8%
415,311
+34.8%
0.00%
Q2 2021$1,994,000
+682.0%
308,141
+1539.0%
0.00%
Q1 2021$255,00018,8000.00%
Other shareholders
GEMINI THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 2,435,125$9,838,0003.06%
Asymmetry Capital Management, L.P. 284,079$1,148,0000.69%
Orbimed Advisors 5,826,224$23,538,0000.26%
Boxer Capital, LLC 1,300,000$5,252,0000.18%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,137,823$8,637,0000.15%
Ikarian Capital, LLC 421,050$1,701,0000.12%
JS Capital Management LLC 474,457$1,917,0000.11%
PURA VIDA INVESTMENTS, LLC 494,400$1,997,0000.06%
HARVARD MANAGEMENT CO INC 250,000$1,010,0000.06%
Atom Investors LP 102,792$415,0000.03%
View complete list of GEMINI THERAPEUTICS INC shareholders